Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F17%3A10370616" target="_blank" >RIV/00216208:11320/17:10370616 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/s10482-017-0895-6" target="_blank" >http://dx.doi.org/10.1007/s10482-017-0895-6</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s10482-017-0895-6" target="_blank" >10.1007/s10482-017-0895-6</a>
Alternative languages
Result language
angličtina
Original language name
Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections
Original language description
With emerging fungal infections and developing resistance, there is a need for understanding the mechanisms of resistance as well as its clinical impact while planning the treatment strategies. Several approaches could be taken to overcome the problems arising from the management of fungal diseases. Besides the discovery of novel effective agents, one realistic alternative is to enhance the activity of existing agents. This strategy could be achieved by combining existing antifungal agents with other bioactive substances with known activity profiles (combination therapy). Azole antifungals are the most frequently used class of substances used to treat fungal infections. Fluconazole is often the first choice for antifungal treatment. The aim of this work was to study potential synergy between azoles and 1,4-dihydropyridine-2,3,5-tricarboxylate (termed derivative H) in order to control fungal infections. This article points out the synergy between azoles and newly synthesized derivative H in order to fight fungal infections. Experiments confirmed the role of derivative H as substrate/inhibitor of fungal transporter Cdr1p relating to increased sensitivity to fluconazole. These findings, plus decreased expression of ERG11, are responsible for the synergistic effect.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10610 - Biophysics
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Antonie van Leeuwenhoek
ISSN
0003-6072
e-ISSN
—
Volume of the periodical
110
Issue of the periodical within the volume
9
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
8
Pages from-to
1219-1226
UT code for WoS article
000407842000011
EID of the result in the Scopus database
2-s2.0-85020238120